Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:FPRX
Tag: NASDAQ:FPRX
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
May 18, 2017
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Departure of Directors...
ME Staff 8-k
-
May 15, 2017
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Other Events
ME Staff 8-k
-
March 20, 2017
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Departure of Directors...
ME Staff 8-k
-
February 14, 2017
0
Cabiralizumab From Five Prime Therapeutics Inc (NASDAQ:FPRX) Obtains Orphan Designation
-
January 25, 2017
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Results of Operations...
ME Staff 8-k
-
January 9, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY) Agrees To Extend Research With Five Prime...
-
January 5, 2017
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Entry into a...
ME Staff 8-k
-
December 14, 2016
0
Bristol-Myers Squibb Co (NYSE:BMY) To Revamp Its Research And Development
Andy Parker
-
December 14, 2016
0
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Files An 8-K Entry into a...
ME Staff 8-k
-
December 13, 2016
0
1
2
Page 2 of 2